BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 23169359)

  • 1. Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen.
    Fernández-Lucas M; Teruel-Briones JL; Gomis-Couto A; Villacorta-Pérez J; Quereda-Rodríguez-Navarro C
    Nefrologia; 2012; 32(6):767-76. PubMed ID: 23169359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
    Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
    Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a pattern of incremental haemodialysis, based on residual renal function, when starting renal replacement therapy.
    Merino JL; Domínguez P; Bueno B; Amézquita Y; Espejo B; Paraíso V
    Nefrologia; 2017; 37(1):39-46. PubMed ID: 28212787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose.
    Vilar E; Wellsted D; Chandna SM; Greenwood RN; Farrington K
    Nephrol Dial Transplant; 2009 Aug; 24(8):2502-10. PubMed ID: 19240122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.
    Portolés J; Moreno F; López-Sánchez P; Mancha J; Gómez M; Corchete E; Del Peso G; Bajo MA; Llópez-Carratalá R; Fernández-Perpén A;
    Nefrologia; 2011; 31(4):441-8. PubMed ID: 21738247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis.
    Korevaar JC; Jansen MA; Dekker FW; Boeschoten EW; Krediet RT
    Adv Perit Dial; 1999; 15():132-7. PubMed ID: 10682088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?
    Koc Y; Unsal A; Basturk T; Sakaci T; Ahbap-Dal E; Sinangil-Arar A; Kose-Budak S; Kayabasi H
    Nefrologia; 2012 May; 32(3):335-42. PubMed ID: 22508142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma.
    Martín-Reyes G; Toledo-Rojas R; Torres-de Rueda Á; Sola-Moyano E; Blanca-Martos L; Fuentes-Sánchez L; Martínez-Esteban MD; Díez-de los Ríos MJ; Bailén-García A; González-Molina M; García-González I
    Nefrologia; 2012; 32(1):35-43. PubMed ID: 22294003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The variable target model: a paradigm shift in the incremental haemodialysis prescription.
    Casino FG; Basile C
    Nephrol Dial Transplant; 2017 Jan; 32(1):182-190. PubMed ID: 27742823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.
    Reddy NC; Korbet SM; Wozniak JA; Floramo SL; Lewis EJ
    Nephrol Dial Transplant; 2007 May; 22(5):1399-406. PubMed ID: 17259652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of furosemide in patients on peritoneal dialysis.
    Flinn A; Ledger S; Blake P
    CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic significance of programmed dialysis in patients who initiate renal substitutive treatment. Multicenter study in Spain].
    Górriz JL; Sancho A; Pallardó LM; Amoedo ML; Martín M; Sanz P; Barril G; Selgas R; Salgueira M; Palma A; de la Torre M; Ferreras I
    Nefrologia; 2002; 22(1):49-59. PubMed ID: 11987685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis dose and frequency.
    Locatelli F; Buoncristiani U; Canaud B; Köhler H; Petitclerc T; Zucchelli P
    Nephrol Dial Transplant; 2005 Feb; 20(2):285-96. PubMed ID: 15598667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could incremental haemodialysis be a new standard of care? A suggestion from a long-term observational study.
    Casino FG; Lopez T; Santarsia G; Mostacci SD; Sabato A; Di Carlo M; Procida C; Saracino A; Deira J; Basile C
    G Ital Nefrol; 2022 Jun; 39(3):. PubMed ID: 35819039
    [No Abstract]   [Full Text] [Related]  

  • 18. Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysis.
    Krishnasamy R; Badve SV; Hawley CM; McDonald SP; Boudville N; Brown FG; Polkinghorne KR; Bannister KM; Wiggins KJ; Clayton P; Johnson DW
    Am J Kidney Dis; 2013 Jan; 61(1):96-103. PubMed ID: 22901771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
    Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.